Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013)
Tenax Therapeutics (TENX) reported Asset Utilization Ratio of 0.36 for Q2 2013, up 469.72% on a YoY basis from 0.06 in Q2 2012, and up 9.33% sequentially from 0.33 in Q1 2013.
Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013) Analysis & Trends
Tenax Therapeutics (TENX) has 3 years of Asset Utilization Ratio data on file, last reported at 0.36 in Q2 2013.
- For the quarter ending Q2 2013, Asset Utilization Ratio rose 469.72% year-over-year to 0.36; the trailing twelve-month figure through Apr 2013 stood at 0.36 (up 469.72% YoY), and the FY2013 full-year result was 0.31, up 202.68% from the prior year.
- Asset Utilization Ratio grew to 0.36 in Q2 2013, from 0.33 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.36 in Q2 2013 to a low of 0.02 in Q3 2011.
- A 3-year average of 0.15 and a median of 0.09 in 2012 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio surged 926.58% in 2012 and soared 469.72% in 2013, its largest moves.
- Tracing TENX's Asset Utilization Ratio over 3 years: stood at 0.02 in 2011, then soared by 926.58% to 0.23 in 2012, then jumped by 54.78% to 0.36 in 2013.
- Business Quant data shows TENX's Asset Utilization Ratio at 0.36 in Q2 2013, 0.33 in Q1 2013, and 0.23 in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 0.36 |
| Jan 31, 2013 | 0.33 |
| Oct 31, 2012 | 0.23 |
| Jul 31, 2012 | 0.12 |
| Apr 30, 2012 | 0.06 |
| Jan 31, 2012 | 0.05 |
| Oct 31, 2011 | 0.02 |
| Jul 31, 2011 | 0.02 |